Detalhe da pesquisa
1.
Trial of Spesolimab for Generalized Pustular Psoriasis.
N Engl J Med
; 385(26): 2431-2440, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936739
2.
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Dermatol Ther (Heidelb)
; 13(1): 347-359, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36333618
3.
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia.
Int J Hematol
; 113(1): 92-99, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951163
4.
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
BMJ Open
; 11(3): e043666, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785490